Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katia Varani

Showing results (61-70 of 239) with videos related to

Pageof 24
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 7, 2002
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertensionKatia Varani, Roberto Manfredini, Valeria Iannotta, et al.
British Journal of Pharmacology|April 27, 2002
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophilsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Purinergic Signalling|April 12, 2008
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptorsStefania Gessi, Katia Varani, Stefania Merighi, et al.
Biochemical Pharmacology|November 6, 2003
Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fieldsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Pharmacological Reviews|November 13, 2014
The A3 adenosine receptor: history and perspectivesPier Andrea Borea, Katia Varani, Fabrizio Vincenzi, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2019
Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A<sub>1</sub>/A<sub>2B</sub> Partial AgonistsDaniela Catarzi, Flavia Varano, Katia Varani, et al.
International Journal of Molecular Sciences|May 14, 2022
A<sub>2A</sub> Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?Stefania Merighi, Manuela Nigro, Alessia Travagli, et al.
Biochemical Pharmacology|February 14, 2002
Binding thermodynamics at the human A(3) adenosine receptorStefania Merighi, Katia Varani, Stefania Gessi, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2007
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxisOlga Bruno, Chiara Brullo, Francesco Bondavalli, et al.
The Journal of Biological Chemistry|March 19, 2005
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Pageof 24

Showing results (61-70 of 239) with videos related to

Sort By:
Pageof 24
Hypertension (Dallas, Tex. : 1979)|December 7, 2002
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertensionKatia Varani, Roberto Manfredini, Valeria Iannotta, et al.
British Journal of Pharmacology|April 27, 2002
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophilsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Purinergic Signalling|April 12, 2008
Novel selective antagonist radioligands for the pharmacological study of A(2B) adenosine receptorsStefania Gessi, Katia Varani, Stefania Merighi, et al.
Biochemical Pharmacology|November 6, 2003
Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fieldsKatia Varani, Stefania Gessi, Stefania Merighi, et al.
Pharmacological Reviews|November 13, 2014
The A3 adenosine receptor: history and perspectivesPier Andrea Borea, Katia Varani, Fabrizio Vincenzi, et al.
Pharmaceuticals (Basel, Switzerland)|October 27, 2019
Amino-3,5-Dicyanopyridines Targeting the Adenosine Receptors Ranging from Pan Ligands to Combined A<sub>1</sub>/A<sub>2B</sub> Partial AgonistsDaniela Catarzi, Flavia Varano, Katia Varani, et al.
International Journal of Molecular Sciences|May 14, 2022
A<sub>2A</sub> Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?Stefania Merighi, Manuela Nigro, Alessia Travagli, et al.
Biochemical Pharmacology|February 14, 2002
Binding thermodynamics at the human A(3) adenosine receptorStefania Merighi, Katia Varani, Stefania Gessi, et al.
Bioorganic & Medicinal Chemistry Letters|May 4, 2007
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: new potent inhibitors of fMLP-induced neutrophil chemotaxisOlga Bruno, Chiara Brullo, Francesco Bondavalli, et al.
The Journal of Biological Chemistry|March 19, 2005
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cellsStefania Merighi, Annalisa Benini, Prisco Mirandola, et al.
Pageof 24